Treating patients with mental illness is complicated by our incomplete understanding of the mechanisms of disease and medication response. Utilizing omics research techniques in psychiatry is a promising method for improving our ability to treat patients with mental illness more effectively and efficiently.
The goal of this Research Topic ill be to provide an overview of the growing use of omics research (including, but not limited to metabolomics, microbiomics, pharmacogenomics, proteomics, and epigenomics) in human subject studies within psychopharmacology research. Ideally, this topic will showcase studies spanning the T1-T4 phases of translational research, which encompasses early proof of concept studies in human participants through translation to large populations and outcomes research.
Example topic themes and article types we are interested in include:
• Utilizing omics techniques in medication outcomes research to improve response or decrease risk of side effects
• Descriptions of pharmacogenomics implementation programs in psychiatry, and analyses of outcomes of such programs
We welcome a variety of article types, including under the following categories: Original Research, Review, Mini Review, Brief Research Report, and Perspective.
Keywords:
Pharmacogenomics, Metabolomics, Epigenomics, Psychotropics, Proteomics, Microbiomics
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Treating patients with mental illness is complicated by our incomplete understanding of the mechanisms of disease and medication response. Utilizing omics research techniques in psychiatry is a promising method for improving our ability to treat patients with mental illness more effectively and efficiently.
The goal of this Research Topic ill be to provide an overview of the growing use of omics research (including, but not limited to metabolomics, microbiomics, pharmacogenomics, proteomics, and epigenomics) in human subject studies within psychopharmacology research. Ideally, this topic will showcase studies spanning the T1-T4 phases of translational research, which encompasses early proof of concept studies in human participants through translation to large populations and outcomes research.
Example topic themes and article types we are interested in include:
• Utilizing omics techniques in medication outcomes research to improve response or decrease risk of side effects
• Descriptions of pharmacogenomics implementation programs in psychiatry, and analyses of outcomes of such programs
We welcome a variety of article types, including under the following categories: Original Research, Review, Mini Review, Brief Research Report, and Perspective.
Keywords:
Pharmacogenomics, Metabolomics, Epigenomics, Psychotropics, Proteomics, Microbiomics
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.